Thomas J Zupancic

This inventor holds 14 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Fundamental Solutions Corporation, Safewhite, Inc., Other. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas J Zupancic. Retrieved from https://idiyas.com/inventor/thomas-j-zupancic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 8)

% Patents Active = 85.7

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 41(Granted Patents)

Location History:

Powell, OH (US) (2013 - 2022)
Powel, OH (US) (2024)

Company Filing History:

10 out of 16

Fundamental Solutions Corporation

1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11857602 - Growth hormone antagonist and anti-cancer composition combination therapy (2024-01-02),

2. 11452763 - Therapeutic pegylated growth hormone antagonists (2022-09-27),

3. 10613083 - Universal biosensor system for analyte detection (2020-04-07),

4. 10241054 - Reaction chambers for use in systems for rapid analysis of biological samples (2019-03-26),

5. 10094783 - Prevention of cross-contamination in systems for rapid analysis of biological samples (2018-10-09),

6. 9850548 - Biosensor system for the rapid detection of analytes (2017-12-26),

7. 9850547 - Biosensor system for the rapid detection of analytes (2017-12-26),

8. 9850546 - Biosensor system for the rapid detection of analytes (2017-12-26),

9. 9752199 - Biosensor system for the rapid detection of analytes (2017-09-05),

10. 9701995 - Test cartridge for use in rapid analysis of biological samples (2017-07-11),

11. 9701994 - System for rapid analysis of biological samples (2017-07-11),

12. 9023640 - Device for rapid detection of infectious agents (2015-05-05),

13. 8784783 - Methods and materials for providing teeth with a white appearance (2014-07-22),

14. 8568698 - Methods and materials for providing teeth with a white appearance (2013-10-29),

Title: Innovations and Contributions of Thomas J Zupancic

Introduction

Thomas J Zupancic is a notable inventor based in Powell, Ohio, with a remarkable portfolio of 14 patents. His work primarily focuses on advancements in medical therapies, particularly in the fields of cancer treatment and growth hormone regulation.

Latest Patents

Among his latest patents, Zupancic has developed a growth hormone antagonist and anti-cancer composition combination therapy. This innovative composition is designed to treat diseases responsive to human growth hormone receptor antagonists. It includes a modified human growth hormone receptor antagonist and an anti-cancer composition. Additionally, he has created a method for treating cancer using these antagonists, which involves pre-screening patients through tumor biopsies to confirm cancer presence and responsiveness to treatment. Another significant patent involves therapeutic pegylated growth hormone antagonists, which are useful in treating conditions such as cancer and acromegaly. These antagonists include specific mutations that enhance their therapeutic efficacy.

Career Highlights

Zupancic has made significant contributions to the field of biotechnology through his innovative research and development. He has worked with companies such as Fundamental Solutions Corporation and Safewhite, Inc., where he has applied his expertise to advance medical technologies.

Collaborations

Throughout his career, Zupancic has collaborated with notable professionals, including Lingchun Zeng and Richard Simon Brody. These collaborations have further enriched his research and development efforts.

Conclusion

Thomas J Zupancic's contributions to medical innovation, particularly in cancer treatment and growth hormone regulation, highlight his role as a leading inventor in his field. His patents reflect a commitment to improving therapeutic options for patients, showcasing the impact of his work on healthcare advancements.

Profile summary based on public USPTO records.